Follow The Filings

WGS Genedx Holdings Corporation

Health Care, filed as GENEDX HOLDINGS CORP (COM CL A), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q3

  • 2 Owners
  • Max 10.5%
  • $484M
  • 1 add

In 2026 Q3 Cathie Wood added to Genedx.

Who owns this now

Largest portfolio weights among holders, up to 10.5% (Corvex Management). Not free-float ownership.

  1. Corvex Management 10.5%
  2. Cathie Wood Add 0.80%

Who owns WGS

Sorted by value, long equity only, as of 2026 Q3.

History
Corvex Management 10.5% Hold 4,784,570 $346M History
Cathie Wood, ARK Investment Management 0.80%, was 0.72% Add +18.8% 1,913,123 $138M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by WGS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All WGS insider trades
  • $107M bought by 2 insiders
  • $6.1M sold by 1 insider outside a trading plan
  • $511K sold by 1 insider under 10b5-1 plans
  1. Casdin Capital, LLC Director, +3 joint filers
    Buy
    $11.1M 200,000 shares at $55.55 +5.7% to stake
    Traded Jun 4–5 Filed Jun 8
  2. Casdin Capital, LLC Director, +3 joint filers
    Buy
    $21.5M 500,000 shares at $42.92 +17% to stake
    Traded May 18–20 Filed May 20
  3. Keith A. Meister Director, +1 joint filer
    Buy
    $13.8M 351,273 shares at $39.19 +7.9% to stake
    Traded May 13–15 Filed May 15
  4. Keith A. Meister Director, +1 joint filer
    Buy
    $46.8M 1,205,147 shares at $38.84 +37% to stake
    Traded May 7–11 Filed May 11
  5. Keith A. Meister Director, +1 joint filer
    Buy
    $13.5M 169,521 shares at $79.40 +5.5% to stake
    Traded Mar 3–5 Filed Mar 5
  6. Bryan Dechairo COO
    Planned sale
    $511K 5,961 shares at $85.70 100% of stake
    Traded Feb 4 Filed Feb 6
  7. Joshua Ruch Director
    Sale
    $6.1M 38,000 shares at $160.37 24% of stake
    Traded Nov 24, 2025 Filed Nov 26, 2025

Also filed in the last 12 months, not counted as buying or selling: 82 sales to cover taxes, 36 option exercises, and 4 stock grants.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
8-K 5.07
8-K 5.02,7.01,9.01
SCHEDULE 13D/A —
SCHEDULE 13D/A —
SCHEDULE 13D/A —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $202.57M $305.45M $427.54M
Gross profit $90.01M $194.4M $298.17M
Gross margin * 44.4% 63.6% 69.7%
Net income -$175.77M -$52.29M -$21.02M
Net margin * -86.8% -17.1% -4.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $182.34M $197.97M $268.29M
Total non-current assets * $236.42M $221.41M $255.42M
Total assets $418.76M $419.38M $523.71M
Total current liabilities $58.82M $54.82M $108.91M
Total non-current liabilities * $131.92M $119.32M $106.62M
Total equity $228.02M $245.25M $308.18M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$180.15M -$28.5M $33.28M
Cash from investing -$43.73M -$30.13M -$61.52M
Cash from financing $186.24M $44.16M $48.02M
Net change in cash -$37.64M -$14.47M $19.79M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf